Spanish Supreme Court provides clarity on patent limitations during invalidity proceedings
In a recent judgment, the Supreme Court clarifies the procedural practice for defendants to raise a patent limitation during invalidity proceedings. In this particular case, the invalidity related to addition of subject matter and lack of inventive step on the patent of the Tiotropium drug.
Background and summary of the case
The case was brought in 2012 by Laboratorios Liconsa S.A. (“Liconsa”) against Boehringer Ingelheim Pharma GmbH &Co (“Boehringer”) before the Barcelona Patent court.
Liconsa filed invalidity proceedings for revocation of Boehringer's patent EP 1.379.220 , validated in Spain under number
Full article available on PatentHub
Latest insights
More Insights
Pantech v Google: Tokyo District Court grants first injunction for SEP infringement
3 minutes Sep 08 2025
EU Revised Product Liability Directive 2024: Navigating the New Liability Framework for Non-EU Manufacturers
6 minutes Sep 04 2025
UPC Litigation Risks for Chinese Firms: Service Delays Could Mean Surprise Judgments
3 minutes Sep 01 2025